Supplements Banned in the EU but OTC in the US (and Vice Versa): The 2026 List

A bottle that is stocked in every US grocery store may be illegal to sell in Paris. A supplement routinely taken in Berlin may be a prescription drug in New York. These gaps are not a matter of culture or taste — they reflect different regulatory philosophies, different risk tolerances, and different historical incidents. This guide catalogues the most significant substances where the US, EU and UK legally part ways in 2026, and explains the specific regulatory reason behind each divergence. Every entry references a real agency action: no rumour, no folklore.

The takeaway is not that one side is right and the other is wrong. It is that "sold legally" means very different things in different places — and that cross-border e-commerce has turned these differences into a practical problem for consumers who travel, relocate, or order internationally. Nutrola's Daily Essentials are formulated at $49/mo to be compliant across EU, UK and North American rules simultaneously, which is why the ingredient list looks more conservative than some US-only competitors.

Substances Legal in the US, Restricted or Banned in the EU

NMN (Nicotinamide Mononucleotide)

NMN is a staple of US longevity shelves but is treated as a novel food in the EU under Regulation 2015/2283. A dossier was submitted for authorisation, but until the European Commission issues a positive decision NMN cannot lawfully be sold as a food supplement in the EU. In 2022-2023 the US FDA itself ruled NMN could not be marketed as a dietary supplement because it had previously been authorised for investigation as a drug — though enforcement has been uneven.

High-Dose Melatonin

Melatonin at low doses (typically up to 1 mg per unit) is permitted as a food supplement in several EU member states with an authorised sleep-related claim. Higher doses are classified as medicinal products in France, Germany, Italy and Spain and require a prescription. In the US, 5 mg and 10 mg melatonin gummies are standard grocery items.

Kava (Piper methysticum)

Kava was restricted across the EU following liver-toxicity reports in the early 2000s. Germany suspended its authorisation; several member states followed. The EFSA has reviewed safety data periodically. In the US, the FDA issued a Consumer Advisory in 2002 but kava remains OTC, typically in herbal sleep and anxiety blends.

5-HTP and L-Tryptophan

5-HTP is widely sold in US supplement stores. It is restricted or prescription-only in several EU states, in part due to the 1989 L-tryptophan eosinophilia-myalgia syndrome (EMS) outbreak — linked to a contaminated manufacturing batch — and subsequent caution about tryptophan-pathway supplements.

Yohimbine

Yohimbine bark extract is a common ingredient in US fat-burners and sexual-health blends. Yohimbine hydrochloride is a prescription medicine in France, Germany and several other EU states.

Red Yeast Rice with Monacolin K

Red yeast rice naturally contains monacolin K, which is chemically identical to lovastatin. EFSA concluded in 2018 that safety concerns exist for monacolin K intakes of 3 mg or more per day from red yeast rice food supplements, and Regulation (EU) 2022/860 effectively restricts monacolins from red yeast rice in EU food supplements. In the US, red yeast rice is sold OTC, though products with standardised monacolin K content walk a legal line with the FDA drug classification of lovastatin.

Substances Legal in the EU, Restricted or Banned in the US

DMAA, DMHA and 1,3-DMBA

1,3-Dimethylamylamine (DMAA) was the target of a series of FDA warning letters starting in 2012 and an FDA 2013 safety communication. The related compounds DMHA and 1,3-DMBA have been subject to similar enforcement. These stimulants were linked to cardiovascular events in users, especially combined with caffeine and exercise. Interestingly, these stimulants are rare in EU products for separate regulatory reasons (novel-food status, stimulant-ingredient caution).

Ephedra (Ma Huang)

The FDA banned ephedrine alkaloid dietary supplements in 2004 following multiple cardiovascular deaths, most prominently the 2003 case involving a professional athlete. Ephedra-containing products cannot be sold in the US. Several EU states restrict ephedra similarly, though herbal ephedra preparations exist in traditional-medicine contexts in some member states.

Phenibut

Phenibut is not recognised as a dietary supplement ingredient by the FDA — which has issued warning letters against companies selling it — but it circulates in grey-market US online retail. It is a prescription medicine in several Eastern European countries and Russia, and was briefly added to Australia's Schedule 9 (prohibited) under the TGA.

Where the UK Differs From Both

Vitamin B6

The UK's Committee on Toxicity has long advised a 10 mg/day guidance for vitamin B6, and products exceeding 10 mg per dose have historically faced additional labelling scrutiny. In 2023-2024 the UK Food Standards Agency consulted on updated tolerable upper levels. The US routinely sells 50 mg and 100 mg B6 supplements with no equivalent restriction.

Melatonin and St John's Wort

Melatonin is a prescription-only medicine in the UK. St John's Wort products making depression claims become medicinal under MHRA and require a Traditional Herbal Registration (THR).

Comparison Table

Substance	US status	EU status	UK status	Main reason for restriction
NMN	Contested (FDA drug-exclusion position)	Not authorised (Novel Food pending)	Same as EU (retained Novel Food rules)	Lack of pre-1997 consumption history
High-dose melatonin (>1 mg)	OTC	Medicinal in FR, DE, IT, ES	Prescription-only (MHRA)	Classified as medicinal product
Kava	OTC (with 2002 FDA advisory)	Restricted or banned in many member states	Restricted	Hepatotoxicity reports
5-HTP	OTC	Restricted/prescription in several states	OTC but controlled quality	Legacy EMS outbreak concerns
Yohimbine HCl	OTC	Prescription in FR, DE and others	Prescription	Cardiovascular risk
Red yeast rice (≥3 mg monacolin K)	OTC	Restricted (Reg. 2022/860)	Restricted	Statin-equivalent action
DMAA	Banned (FDA 2012-2013 enforcement)	Not authorised	Not authorised	Cardiovascular events
Ephedra	Banned (2004)	Restricted	Restricted	Cardiovascular deaths
Phenibut	Not recognised; warning letters	Prescription in several states	Not a licensed medicine	Dependence potential
Vitamin B6 ≥10 mg	OTC (commonly 50-100 mg)	Variable national upper levels	Additional scrutiny >10 mg	Peripheral neuropathy at high chronic doses

Why the Gaps Exist

Different Default Assumptions

DSHEA 1994 assumes an ingredient is safe unless proven otherwise. EU Novel Food Regulation 2015/2283 assumes an ingredient is not permitted unless demonstrated to have been consumed safely before 15 May 1997 or authorised after EFSA review. The default flips.

Historical Incidents

L-tryptophan EMS (1989), ephedra deaths (early 2000s), DMAA cases (2010s) and kava hepatotoxicity (early 2000s) each reshaped regulation in different jurisdictions on different timelines, leaving behind a patchwork.

Medicinal Classification Borders

A substance is a "medicine" in one jurisdiction and a "food" in another based on administrative decisions about function, dose and presentation. Melatonin is the clearest example of how the same molecule sits on either side of that line.

What This Means for Consumers

If you move between jurisdictions, do not assume your stack is legal or even available in the new country. Reorder from local retailers rather than importing. Be particularly careful with melatonin, kava, NMN and higher-dose B6 when crossing the Atlantic. Nutrola's Daily Essentials, EU certified and lab tested, are formulated to travel cleanly across jurisdictions — which is a deliberate design choice, not an accident.

Frequently Asked Questions

Can I bring NMN into the EU for personal use?

Customs enforcement focuses on commercial shipments, but seizures of personal packages have occurred. Because NMN is an unauthorised novel food, there is no lawful sale channel in the EU in 2026.

Is melatonin really illegal in France?

Doses above roughly 1-2 mg are classified as medicinal and require a prescription. Lower-dose food-supplement melatonin is available in pharmacies. The classification is about dose and presentation, not about melatonin itself being illegal.

Why is red yeast rice a drug in the EU but a supplement in the US?

Monacolin K from red yeast rice is chemically lovastatin, a prescription statin. EU law restricts monacolin K content in food supplements to avoid back-door sale of a statin as food. US enforcement has been less consistent.

Did the FDA actually ban ephedra?

Yes. The FDA's 2004 final rule declared dietary supplements containing ephedrine alkaloids adulterated and banned their sale. The rule was upheld on appeal.

Are DMAA and ephedra the same thing?

No. Both are sympathomimetic stimulants and both were banned after cardiovascular events, but DMAA (1,3-dimethylamylamine) is a synthetic compound whereas ephedra is a plant containing ephedrine alkaloids.

Citations

1. U.S. Food and Drug Administration. Warning Letters on DMAA (2012-2013).
2. U.S. Food and Drug Administration. Final Rule: Dietary Supplements Containing Ephedrine Alkaloids, 2004.
3. EFSA Panel on Food Additives and Nutrient Sources. Scientific Opinion on the safety of monacolins in red yeast rice, 2018.
4. European Commission. Regulation (EU) 2022/860 amending Annex III to Regulation (EC) No 1925/2006 (monacolins from red yeast rice).
5. Centers for Disease Control and Prevention. Eosinophilia-Myalgia Syndrome and L-Tryptophan, MMWR 1989-1990.
6. UK Food Standards Agency. Vitamin B6 tolerable upper level consultation documents.
7. European Parliament and Council. Regulation (EU) 2015/2283 on novel foods.